Lavoltidine

Names

[ Name ]:
Lavoltidine

[Synonym ]:
LAVOLTIDINE
Lavoltidina
Lavoltidinum
[1-methyl-5-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]-1,2,4-triazol-3-yl]methanol
Loxtidinum
Loxtidina
Loxtidine
Lavoltidinum [INN-Latin]
Loxtidinum [Latin]
Lavoltidine [INN:BAN]
Loxtidina [Spanish]

Biological Activity

[Description]:

Lavoltidine (Loxtidine) is an an orally active, irreversible and highly potent histamine H2-receptor antagonist. Lavoltidine strongly inhibits gastric acid secretion and also induces hypergastrinemia[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Immunology/Inflammation >> Histamine Receptor

Signaling Pathways >> GPCR/G Protein >> Histamine Receptor

[Target]

H2 Receptor

[In Vivo]

Lavoltidine (Loxtidine; 0.5 g/L; orally (drinking water); changed weekly; for 3 months) shows partial suppression of both gastric acid secretion and progression to neoplasia. Lavoltidine inhibits gastric atrophy, hyperplasia, and dysplasia in H felis-infected INS-GAS mice[1]. Lavoltidine treatment for 6 months inhibits gastric tumors in H felis-infected INS-GAS mice[1]. Animal Model: Male hypergastrinemic mice (INS-GAS mice) infected with Helicobacter felis[1] Dosage: 0.5 g/L Administration: Orally (drinking water); changed weekly; for 3 months Result: Showed partial suppression of both gastric acid secretion and progression to neoplasia.

[References]

[1]. Takaishi S, et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.

Chemical & Physical Properties

[ Density]:
1.23g/cm3

[ Boiling Point ]:
566.9ºC at 760 mmHg

[ Molecular Formula ]:
C₁₉H₂₉N₅O₂

[ Molecular Weight ]:
359.46600

[ Flash Point ]:
296.6ºC

[ Exact Mass ]:
359.23200

[ PSA ]:
75.44000

[ LogP ]:
2.18520

[ Index of Refraction ]:
1.614

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.